排序方式: 共有3条查询结果,搜索用时 78 毫秒
1
1.
Meng Lei Huayun Feng Enhe Bai Hui Zhou Jia Wang Jingmiao Shi Xueyuan Wang Shihe Hu Zhaogang Liu Yongqiang Zhu 《Bioorganic & medicinal chemistry》2018,26(14):3975-3981
A series of novel dipeptidyl boronic acid inhibitors of 20S proteasome were designed and synthesized. Aliphatic groups at R1 position were designed for the first time to fully understand the SAR (structure–activity relationship). Among the screened compounds, novel inhibitor 5c inhibited the CT-L (chymotrypsin-like) activity with IC50 of 8.21?nM and the MM (multiple myeloma) cells RPMI8226, U266B and ARH77 proliferations with the IC50 of 8.99, 6.75 and 9.10?nM, respectively, which showed similar in vitro activities compared with the compound MLN2238 (biologically active form of marketed MLN9708). To investigate the oral availability, compound 5c was esterified to its prodrug 6a with the enzymatic IC50 of 6.74?nM and RPMI8226, U266B and ARH77 cell proliferations IC50 of 2.59, 4.32 and 3.68?nM, respectively. Furthermore, prodrug 6a exhibited good pharmacokinetic properties with oral bioavailability of 24.9%, similar with MLN9708 (27.8%). Moreover, compound 6a showed good microsomal stabilities and displayed stronger in vivo anticancer efficacy than MLN9708 in the human ARH77 xenograft mouse model. Finally, cell cycle results showed that compound 6a had a significant inhibitory effect on CT-L and inhibited cell cycle progression at the G2M stage. 相似文献
2.
Interference is said to take place whenever crossover events fail to occur at random along the chromosome. The nature of higher order interference (positive or negative) is introduced. It is shown how interference is determined by the chiasma formation process operating along the chromosome and especially by the count-location (C-L) chiasma formation process. We discuss a simple mechanism among C-L processes that can generate prescribed higher order positive interference or prescribed higher order negative interference between any two collections of disjoint genomic regions.Supported in part by NIH grant GM 28016 相似文献
3.
目的:构建SDH-SV2C-L4融合蛋白表达载体,在大肠杆菌中表达具有山梨糖脱氢酶(SDH)活性的融合蛋白。方法:将C亚型突触囊泡蛋白2大突环L4(SV2C-L4)基因与SDH基因以GGGS柔性接头连接,在大肠杆菌DH5α中表达;用NBT染色和DCIP脱色的方法检测融合蛋白的SDH活性。结果:DNA测序及SDS-PAGE结果显示构建了融合蛋白表达载体,并表达了SDH-SV2C-L4融合蛋白,相对分子质量约80×103;DCIP脱色及NBT染色均检测到融合蛋白的SDH活性。结论:与SV2C-L4融合的SDH仍具有活性,为下一步SV2C-L4活性检测方法的建立及SDH与SV2C-L4的其他相关研究奠定了基础。 相似文献
1